7:55am ET
Health and Healthcare
Short Sellers Back Off Big Biotech
24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 5:36am ET
GILD Coverage
Page 331:45pm ET
Health and Healthcare
Is Gilead Headed Lower From Here?
Merrill Lynch recently updated its view on Gilead Sciences, maintaining its Underperform rating for the stock but raising its price objective
Chris Lange 7:50am ET
Health and Healthcare
Short Sellers Get More Selective on Big Biotech
The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech stocks was mixed.
7:55am ET
Health and Healthcare
Short Sellers Lose Some Conviction Against Big Biotech
The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech stocks, short interest has decreased.
8:25am ET
Health and Healthcare
Short Sellers Get Even More Ambitious Against Biotech Leaders
The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of stocks.
9:15am ET
Investing
Large Companies With Fastest Revenue and Earnings Growth in 2015
S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.
9:30am ET
Health and Healthcare
The Most Loved Biotechs of Big Hedge Funds
There were some interesting positions of hedge funds in biotech, long and short, from the Goldman Sachs Hedge Fund Trend Monitor.
8:05am ET
Investing
10 Companies to Own for the Next Decade
Back in November of 2010, 24/7 Wall St. first issued a list of stocks to own for the next decade. Even long-term investors need to assess their portfolios from time to time.
1:00pm ET
Investing
Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets
It turns out that hedge fund Bridgewater Associates and founder Ray Dalio have made some changes since the end of 2014.
8:05am ET
Health and Healthcare
Short Sellers Start to Get Nervous on Biotech
The short interest data are out for the April 30 settlement date, and for most of the selected biotech stocks, short interest is down.
4:30pm ET
Health and Healthcare
Gilead Avoids the Earnings Hangman
Gilead Sciences reported better than expected first-quarter results Thursday after the markets closed.
Chris Lange 3:33pm ET
Health and Healthcare
What to Expect From Gilead Earnings
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) will report its first-quarter earnings Thursday after the markets close. Thomson Reuters has consensus estimates of $2.32 in earnings per share (EPS) on $6.92 billion in revenue.…
Chris Lange 8:30am ET
Health and Healthcare
Short Sellers Become More Wary of Big Biotech
The short interest data are out for the April 15 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
1:10pm ET
Health and Healthcare
Opposing Views on Gilead Hepatitis C Presentation
Gilead Sciences is a major biotech involved with the EASL conference, and two analysts are calling heads and tails in terms of what the HCV news means for the stock.
Chris Lange 9:15am ET
Investing
5 Stocks to Buy for Big Revenue Growth
In a new research note, Jefferies reviewed the 12-month change in revenue growth for the largest 30 companies in the S&P 500.
